May-Jun 2008
Salicylaldehyde Based Oxazolidines
877
25
(1R,2S)-2-Isopropylamino-1-phenyl-1-propanol (9). [α]D
= -10.3 (c 1.28, CHCl3). Mp = 99-101 oC. 1H NMR: δ 0.80 (d,
J = 6.6 Hz, 3H), 1.10 (t, J = 7.2 Hz, 6H), 2.97 (m, 1H), 3.05 (dq,
J = 4.0, 6.6 Hz, 1H), 4.70 (d, J = 4.0 Hz, 1H), 7.23-7.35 (m,
5H). Characterization data for this compound matched the
identical compound found in the literature [9b].
(1R,2S)-2-(Benzylamino)-1-phenyl-1-propanol (10). [18]
Using benzaldehyde, the title compound was obtained in 99%
yield as a clear oil. Rf = 0.42 (90:10 hexanes/EtOAc). [α]D25 = -
30.0 (c 0.86, CHCl3). 1H NMR (CDCl3): δ 0.86 (d, J = 6.6 Hz,
3H), 3.01 (dq, J = 6.6, 3.5 Hz, 1H), 3.89 (s, 2H), 4.80 (d, J = 3.5
Hz, 1H), 7.26-7.35 (m, 10H). 13C NMR (CDCl3): δ 14.7, 51.4,
58.1, 73.9, 126.6, 127.4, 127.5, 128.4, 128.5, 128.9, 140.3,
142.2. IR (CHCl3): 3406, 3028, 1603, 1028, 732, 700 cm-1.
HRMS (ESI) calcd for C16H20NO (M + H)+: 242.1535 Found:
242.1545.
(1R,2S)-2-Cyclohexylamino-1-phenyl-1-propanol (11). The
purified product was isolated via recrystallization (ethyl
acetate/hexanes) in 85% yield. Mp: 89-91 °C. [α]D25 = +11.2 (c
1.66, CH2Cl2). 1H NMR (CDCl3): δ, 0.78 (d, J = 6.6 Hz, 3H),
1.00-1.34 (m, 7H), 1.59-1.64 (m, 1H), 1.71-1.75 (m, 1H), 1.85-
1.96 (m, 1H), 2.52-2.59 (m, 1H), 3.05-3.11 (m, 1H), 4.66 (d, J =
4.0 Hz, 1H), 7.21-7.34 (m, 5H). 13C NMR (CDCl3): δ, 12.7,
24.8, 24.9, 25.5, 31.8, 32.5, 54.3, 55.8, 72.4, 126.0, 127.0, 128.0,
140.9. IR (nujol mull): 3278, 1102, 738, 701 cm-1. ESI-HRMS
calcd for C15H23NO (M + H)+: 234.1858. Found: 234.1858.
General Procedure for Oxazolidine Synthesis with 2-
hydroxybenzaldehyde. To a flame dried, nitrogen purged flask
was added 9 (2.05 g, 10.6 mmol), methanol (45 mL), 2-
hydroxybenzaldehyde (1.12 mL, 10.6 mmol), and sodium sulfate
(7.50 g, 53.2 mmol). The mixture was stirred under reflux for
17 hours and filtered through Celite. Excess solvent was
removed under reduced pressure and the product was
recrystallized with ethyl ether and hexanes (1:2).
3411, 1607, 1168, 755, 703 cm-1. ESI-HRMS calcd for
C27H40NO2 (M + H)+: 410.3059. Found: 410.3060.
General Procedure for the Addition of Diethylzinc to
Aldehydes. Oxazolidine 12 (0.088 g, 0.29 mmol) was added
with toluene (4 mL) to a flame dried flask in an inert
atmosphere. A solution of diethylzinc in hexanes (1M, 8.92 mL)
was added and allowed to stir at room temperature for 25
minutes. At that time, benzaldehyde (0.30 mL, 2.97 mmol) was
added and allowed to stir at room temperature for 24 hours. The
reaction was quenched with a saturated ammonium chloride
solution (50 mL) and the corresponding alcohol was extracted
using ethyl acetate (50 mL x 2). The alcohol was washed with
brine, dried with magnesium sulfate, gravity filtered, and
concentrated under reduced pressure.
Chiral Stationary Phase HPLC (CSP HPLC) analysis.
The enantioselectivity of the asymmetric addition of diethylzinc
to the carbonyl compounds was determined after the reactions
were quenched and extracted. The determination was carried
out via chiral stationary phase HPLC. A Chiralcel-OD column
was employed with a UV detector operating at 254 nm. The
solvent system was composed of a mixture of hexanes and
isopropanol (99.5:0.5) and the flow rate was 1 mL/min.
1-Phenyl-1-propanol: tR = 11.8 (R) and 14.8 (S) min.
1-(4-Methoxyphenyl)propan-1-ol: tR = 16.3 (R) and 19.3 (S)
min.
1-(4-Chlorophenyl)propan-1-ol: The product of the addition
of diethylzinc with 4-chlorobenzaldehyde was derivatized with
2-naphthoyl chloride. Retention time for 1-(4-chlorophenyl)-
propan-1-ol (as naphthoate): tR = 12.8 (R) and 10.6 (S) min.
1-Phenyl-1-penten-3-ol: tR =22.8 (R) and 43.1 (S) min.
3-Octanol: The product of the diethylzinc addition to
hexanal was derivatized as the 2-naphthoate derivative: tR
20.2 (R) and 18.9 (S) min.
=
Acknowledgements. This research was funded in part by a
Research Enhancement Award from Illinois State University's
College of Arts & Sciences. The authors gratefully acknowledge
support for this work, in part, by the National Science
Foundation (NSF grant# CHE 644950) and the donors of the
Petroleum Research Fund as administered by the American
Chemical Society (PRF grant # B 40777-1).
2-[(2S,4S,5R)-3-Isopropyl-4-methyl-5-phenyloxazolidin-2-
yl] phenol (12). Using 2-hydroxybenzaldehyde and 9, the title
25
compound was obtained as white crystals (40%). [α]D
=
-133.6 (c 0.43, CH2Cl2). Mp = 96-98 ºC. 1H NMR (CDCl3): δ
0.88 (d, J = 7.2 Hz, 3H), 1.14 (d, J = 6.6 Hz, 3H), 1.21 (d, J =
6.6 Hz, 3H), 3.09 (septet, J = 6.6 Hz, 1H), 3.55 (pentet, J = 6.6
Hz, 1H), 5.09 (d, J = 7.2 Hz, 1H), 5.38 (s, 1H), 6.81-6.87 (m,
2H), 7.18-7.31 (m, 7H), 12.29 (br s, 1H). 13C NMR (CDCl3): δ
18.8, 19.3, 21.6, 50.7, 57.6, 81.1, 81.2, 95.2 (epimer), 95.3
(epimer), 117.0, 118.8, 120.8, 126.4, 127.6, 128.1, 130.2
(epimer), 130.3 (epimer), 136.6, 158.7. IR (nujol mull): 1174,
753, 712, 702 cm-1. ESI-HRMS calcd for C19H24NO2 (M + H)+:
298.1807. Found: 298.1817.
REFERENCES AND NOTES
[1] Pu, L.; Yu, H.-B. Chem. Rev. 2001, 101, 757-824.
[2] Soai, K.; Niwa, S. Chem. Rev. 1992, 92, 833-856.
[3] Falorni, M.; Collu, C.; Conti, S.; Giacomelli, G.
Tetrahedron: Asymm. 1996, 7, 293-299.
2,4-Di-tert-butyl-6-((2S,4S,5R)-3-isopropyl-4-methyl-5-
phenyloxazolidin-2-yl)phenol (13). Using 3,5-di-tert-butyl-2-
hydroxybenzaldehyde and 9, the title compound was obtained as
white crystals (11%). [α]D25 = -72.2 (c 0.30, CHCl3). Mp = 94-
96 ºC. 1H NMR (CDCl3): δ 0.88 (epimer, d, J = 7.2 Hz, 3H),
0.90 (d, J = 6,6 Hz, 3H), 1.15 (d, J = 6.6 Hz, 3H), 1.20 (d, J =
6.6 Hz, 3H), 1.30 (s, 9H), 1.45 (s, 9H), 3.09 (epimer, septet, J =
6.6 Hz, 1H), 3.12 (septet, J = 6.6 Hz, 1H), 3.58 (pentet, J = 6.6
Hz, 1H), 5.09 (d, J = 7.2 Hz, 1H), 5.36 (s, 1H), 7.04 (d, J = 2.0
Hz, 1H), 7.25-7.37 (m, 5H), 12.15 (br s, 1H). 13C NMR
(CDCl3): δ 14.8 (epimer), 18.1, 19.3 (epimer), 21.6 (epimer),
23.1 (epimer), 23.3, 29.5, 31.7, 34.1 (epimer), 35.0, 45.9
(epimer), 49.9, 55.4 (epimer), 56.9, 73.2, 81.4, 96.2, 119.4,
124.6, 125.0, 126.1, 126.7 (epimer), 127.0, 127.6, 128.0
(epimer), 128.1, 136.1, 137.2, 139.9, 155.5. IR (nujol mull):
[4a] Kang, Y.-F.; Liu, L. Synth. Commun. 2005, 35, 1819-1823.
[b] Kang, Y.-F.; Liu, L.; Wang, R.; Zhou, Y.-F.; Yan, W.-J. Adv. Syn.
Cat. 2005, 347, 243-247. [c] Kang, Y.-F.; Wang, R.; Liu, L.; Da, C.-S.;
Yan, W.-J.; Xu, Z.-Q. Tetrahedron Lett. 2005, 46, 863-865.
[5a] (a) Braga, A. L.; Appelt, H. R.; Silveira, C. C.; Wessjohann,
L. A.; Schneider, P. H. Tetrahedron 2002, 58, 10413-10416. (b) Braga,
A. L.; Rodrigues, O. E. D.; Paixao, M. W.; Appelt, H. R.; Silveira, C. C.;
Bottega, D. P. Synthesis 2002, 16, 2338-2340.
[6a] H Nakano, H.; Okuyama, Y.; Fushimi, K.; Yamakawa, R.;
Kayaoka, D.; Hongo, H. Heterocycles 2002, 56, 457-466. [b] Nakano,
H.; Okuyama, Y.; Iwasa, K.; Hongo, H. Heterocycles 2001, 54, 411-418.
[7] Ge, J. F.; Shen, Z. X.; Zhang, Y. W.; Lu, X. H.; Lu, Z. E.
Chin. J. Chem. 2003, 21, 950-954.
[8] Parrott II, R. W.; Hitchcock, S. R. Tetrahedron: Asymm.
2007, 18, 377-382.
[9a] Baxter, E. W.; Reitz, A. B. “Reductive Aminations of